Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular prognostic factors in cytogenetically normal acute myeloid leukemia.

Expert review of hematology - 1 Oct 2012

Walker Alison, Marcucci Guido

Abstract excerpt

Chromosomal abnormalities are detected in 50-60% of patients with acute myeloid leukemia (AML) and are important predictors of prognosis and risk of relapse. The remaining patients, those with cytogenetically normal AML, are a seemingly homogeneous group that in fact consists of subsets of patients with distinct clinical outcomes. This heterogeneity is likely related to acquired gene mutations, as well as altered...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to DNA (Cytosine-5-)-Methyltransferases
Share to Gene Expression Profiling
Share to Isocitrate Dehydrogenase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Leukemia, Myeloid, Acute

Share to MicroRNAs

Share to Neoplasm Proteins

Share to Nuclear Proteins

Share to Receptor Protein-Tyrosine Kinases

Source

Open in PubMed Open full text

Identifiers

PMID: 23146058
DOI: 10.1586/ehm.12.45
PMCID: PMC3582378

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular prognostic factors in cytogenetically normal acute myeloid leukemia.PMID 23146058Read ↗

Emerging molecular predictive and prognostic factors in acute myeloid leukemia.Semantic proximity Read ↗

Clinical implications of molecular markers in acute myeloid leukemia.Semantic proximity Read ↗

Molecular heterogeneity and prognostic biomarkers in adults with acute myeloid leukemia and normal cytogeneticsSemantic proximity Read ↗

Novel Prognostic and Therapeutic Mutations in Acute Myeloid Leukemia.Semantic proximity Read ↗

Prognostic implications of genetic aberrations in acute myelogenous leukemia with normal cytogenetics.Semantic proximity Read ↗

Molecular Genetic Markers in Acute Myeloid LeukemiaSemantic proximity Read ↗

Molecular characterization of acute myeloid leukemia and its impact on treatment.Semantic proximity Read ↗

The genomic landscape of acute myeloid leukemia: Redefining classifications, ontogeny, and therapeutic strategies.Semantic proximity Read ↗

Genomic landscape in acute myeloid leukemia and its implications in risk classification and targeted therapiesSemantic proximity Read ↗

Prognostic factors in acute myeloid leukemia.Semantic proximity Read ↗

Impact of genomics in the clinical management of patients with cytogenetically normal acute myeloid leukemia.Semantic proximity Read ↗

The changing paradigm of prognostic factors in acute myeloid leukaemia.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.